The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 6 May 2003
doi: 10.1242/jcs.00461
Research Article
NF-
B signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms
Glyn Nelson,
Geraint J.C. Wilde,
David G. Spiller,
Stephnie M. Kennedy,
David W. Ray,
Elaine Sullivan,
John F. Unitt,
and
Michael R.H. White*
* Author for correspondence (e-mail: mwhite{at}liv.ac.uk)
NF-
B transcription factors are involved in the cellular response to stress, and are regulated by inhibitor (I
B) proteins, which prevent NF-
B-mediated transcription by maintaining NF-
B in the cytoplasm. Proteins from other pathways are also known to regulate NF-
B negatively, notably the glucocorticoid receptor (GR) and IL-4- responsive STAT6. Both pathways were shown to inhibit NF-
B-mediated transcription, by expressing either STAT6 or GR and activating the respective pathways. Using fluorescent fusion proteins, we show that GR alters the timing of activated p65 NF-
B nuclear occupancy by increasing the export rate of p65 and is independent of whether GR is present as a dimer or monomer. Expression of STAT6 was also shown to alter p65 nuclear occupancy but appeared to affect the import rate and hence the overall maximal level of p65 translocation. Activating STAT6 with IL-4 prior to activating NF-
B significantly increased this inhibition. Investigation of I
B
showed that activated STAT6 inhibited TNF
-mediated I
B
phosphorylation and degradation, whereas GR activation did not alter I
B
kinetics. This demonstrates a clear separation of two distinct mechanisms of inhibition by STAT6 and GR upon the NF-
B pathway.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. L A Souza, E. Gurgul-Convey, M. Elsner, and S. Lenzen
Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells
J. Endocrinol.,
April 1, 2008;
197(1):
139 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias
Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13
J. Immunol.,
November 15, 2007;
179(10):
7030 - 7041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. McMaster and D. W. Ray
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects
Exp Physiol,
March 1, 2007;
92(2):
299 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shen, G. Nelson, D. E Nelson, S. Kennedy, D. G Spiller, T. Griffiths, N. Paton, S. G Oliver, M. R.H White, and D. B Kell
Automated tracking of gene expression in individual cells and cell compartments
J R Soc Interface,
December 22, 2006;
3(11):
787 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marcais, C.-A. Coupet, T. Walzer, M. Tomkowiak, R. Ghittoni, and J. Marvel
Cell-Autonomous CCL5 Transcription by Memory CD8 T Cells Is Regulated by IL-4
J. Immunol.,
October 1, 2006;
177(7):
4451 - 4457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. M. Schaaf, L. Willetts, B. P. Hayes, B. Maschera, E. Stylianou, and S. N. Farrow
The Relationship between Intranuclear Mobility of the NF-{kappa}B Subunit p65 and Its DNA Binding Affinity
J. Biol. Chem.,
August 4, 2006;
281(31):
22409 - 22420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Kirton, F. L. Wilkinson, A. E. Canfield, and M. Y. Alexander
Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes: Implications for Vascular Calcification
Circ. Res.,
May 26, 2006;
98(10):
1264 - 1272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Friedrichsen, C. V. Harper, S. Semprini, M. Wilding, A. D. Adamson, D. G. Spiller, G. Nelson, J. J. Mullins, M. R. H. White, and J. R. E. Davis
Tumor Necrosis Factor-{alpha} Activates the Human Prolactin Gene Promoter via Nuclear Factor-{kappa}B Signaling
Endocrinology,
February 1, 2006;
147(2):
773 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Nelson, C. A. Horton, V. See, J. R. Johnson, G. Nelson, D. G. Spiller, D. B. Kell, and M. R. H. White
Response to Comment on "Oscillations in NF-{kappa}B Signaling Control the Dynamics of Gene Expression"
Science,
April 1, 2005;
308(5718):
52b - 52b.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Nelson, A. E. C. Ihekwaba, M. Elliott, J. R. Johnson, C. A. Gibney, B. E. Foreman, G. Nelson, V. See, C. A. Horton, D. G. Spiller, et al.
Oscillations in NF-{kappa}B Signaling Control the Dynamics of Gene Expression
Science,
October 22, 2004;
306(5696):
704 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, M. G. Malabarba, Z. S. Nagy, and R. A. Kirken
Interleukin 4 Regulates Phosphorylation of Serine 756 in the Transactivation Domain of Stat6: ROLES FOR MULTIPLE PHOSPHORYLATION SITES AND Stat6 FUNCTION
J. Biol. Chem.,
June 11, 2004;
279(24):
25196 - 25203.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003